Clinical Trial Update: Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains [NA]

View source ↗

Summary

A completed clinical trial evaluating the GenePOC GBS assay for detecting the Cfb gene in Streptococcus agalactiae strains, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcus Agalactiae Infection

Drugs mentioned

• GenePOC GBS assay (GBS assay)

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Streptococcus Agalactiae Infection | NA | Status: COMPLETED | Results posted: 2018-12-13